academic article

• Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes..  Clinical cancer research : an official journal of the American Association for Cancer Research.  23:3794-3801. 2017